.svg){kind=small}
Visionary Healthcare Leader, Transformative Entrepreneur and Philanthropic Advocate.
.svg)
.svg)
.svg)
.svg)
.svg)
Strategic Leadership & Growth: Founded and scaled Bank’s Apothecary from a startup to $300M in annual revenue, serving 150,000+ patients across 16 states. Built the largest independently held behavioral health specialty pharmacy in the U.S.
Value Creation & Operational Excellence: $300M ARR in 12 years. Tripled EBITDA (2018–2022) through cost optimization, operational improvements, and strategic planning. Led an inhouse team of 30+ employees with a retention rate exceeding 98%.
Financial Analysis & Business Optimization: Designed proprietary in-house systems for prior authorization, patient eligibility, drug acquisition, and fulfillment, eliminating reliance on third parties and safeguarding value integrity.
M&A and Private Equity Advisory: Advised Fortune 500 companies on healthcare acquisitions, roll-ups, and small business exits to private equity. Conducted diligence for $200M+ in transactions and optimized portfolio performance of underlying companies
Partnership Development: Negotiated exclusive agreements with manufacturers, PBMs, and healthcare plans, securing access to 15 Limited Distribution Drugs (LDDs).
Change Management & Organizational Resilience: Maintained 100% operational uptime during COVID-19, ensuring uninterrupted patient care. Achieved 99% employee retention and 98% provider retention through effective in-house growth and engagement strategies
(2010 to 2022)
• Led the company from inception to $300M annual revenue, serving over 150,000 patients annually across 16 states.
• Achieved unprecedented valuation in a successful private equity acquisition in 2022.
• Secured exclusive agreements with PBMs, healthcare plans, and manufacturers, managing 15 Limited Distribution Drugs (LDDs) across 16 states.
• Tripled EBITDA from 2018 to 2022 by optimizing operations and implementing strategic initiatives.
• Delivered uninterrupted services during the COVID-19 pandemic, demonstrating resilience and leadership. Achieved 99% employee retention and 98% provider retention.
(2023 to Present)
• Provide strategic consulting to private equity firms and healthcare ventures, including Morgan Stanley, focusing on M&A growth strategies, and operational optimization.
• Identified high-value investment opportunities through in-depth evaluations of deal flow for smaller valued companies to help supercharge growth.
• Supported clients in navigating complex regulatory landscapes and achieving sustainable growth. Helped diligence FDA compliance with compounding pharmacies, URAC/ACHC accreditation evaluation. Diligence state and federal laws for use of reverse distrubutors, 3rd party pharmacy vendor use. Helped numerous companies create valuation creation (3-8x) of EBITDA.
• Member, Board of Directors, Liguori Academy (2024 – Present)
• Advisory Board Member, Temple University School of Pharmacy (2023 – Present)
• Executive Advisory Council Member, University of Washington School of Pharmacy (2023 – Present)
• Member, Board of Directors, Eye Foundation of America (2003 - Present)
• Founded the Maddula Foundation, contributing millions to healthcare and education initiatives.
• Advocate for mental health awareness and healthcare equity through public speaking and mentorship.
• Keynote speaker at leading institutions, sharing insights on healthcare innovation and strategic leadership.
Rutgers University, Ernest Mario School of Pharmacy (2009)
.png)